News
DDi wins ‘Best Global Regulatory & Clinical Development Partner 2025’ Award by GHP
DDi, a global leader in regulatory and clinical development solutions for the life sciences industry, has been honored with the prestigious ‘Best Global Regulatory & Clinical Development Partner 2025’ award by Global Health & Pharma (GHP). This recognition marks a significant milestone in DDi’s commitment to driving innovation and excellence across regulatory, clinical, and technology-driven services.
Presented as part of GHP’s annual International Life Sciences Awards, this accolade celebrates DDi’s exceptional performance, client-centric approach, and continued impact on advancing healthcare solutions worldwide. The award underscores DDi’s strengths in delivering efficient, compliant, and technology-enabled services that accelerate drug development and regulatory approvals.
Speaking on the win, DDi’s CEO expressed gratitude to their dedicated teams and loyal clients, crediting this achievement to their shared vision of improving global health outcomes through smarter, faster, and more integrated development strategies.
This award not only solidifies DDi’s global reputation but also sets the stage for continued innovation and leadership in the regulatory and clinical space.
Let's talk about how DDi can help you